# DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial

Study · id `cardio:ct-nct07229248` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07229248](<https://clinicaltrials.gov/study/NCT07229248>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07229248

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 496 participants.

## Technical summary

Registry record NCT07229248. Randomized; single masking; primary purpose treatment. Start 2025-11-05 (anticipated); primary completion 2027-12-17 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 496 participants (planned count; ClinicalTrials.gov record NCT07229248, source copy `cardio:ctgov-nct07229248-2025-11-14`, retrieved 2026-10-26)
- Planned start: 2025-11-05 (anticipated) (ClinicalTrials.gov record NCT07229248, source copy `cardio:ctgov-nct07229248-2025-11-14`, retrieved 2026-10-26)
- Primary completion: 2027-12-17 (anticipated) (ClinicalTrials.gov record NCT07229248, source copy `cardio:ctgov-nct07229248-2025-11-14`, retrieved 2026-10-26)
- Completion: 2027-12-26 (anticipated) (ClinicalTrials.gov record NCT07229248, source copy `cardio:ctgov-nct07229248-2025-11-14`, retrieved 2026-10-26)
- Countries: Pakistan (ClinicalTrials.gov record NCT07229248, source copy `cardio:ctgov-nct07229248-2025-11-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07229248-2025-11-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial
- Acronym: DCB-STEMI
- Condition: STEMI (ST Elevation MI)
- Intervention (Device): Drug coated balloon (Prevail; Medtronic Inc.)
- Intervention (Device): Drug eluting stent
- Lead sponsor: National Institute of Cardiovascular Diseases, Pakistan
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: National Institute of Cardiovascular Diseases, Pakistan (`cardio:org-national-institute-of-cardiovascular-diseases-pakistan`)

## Provenance

Content hash: 8bfca05b76c8cb1af9f7d0f23437894dfb724192702a1cc2d6ef041b5e66055b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
